Universal-Beteiligungs- und Servicegesellschaft’s Vanda Pharmaceuticals VNDA Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30,000	Closed	-$207K	–	2205
2026 Q1	$207K	Buy	30,000 +10,000	+50%	+$77.1K	﹤0.01%	1979
2025 Q4	$141K	Sell	20,000 -160,000	-89%	-$881K	﹤0.01%	2012
2025 Q3	$898K	Hold	180,000	–	–	﹤0.01%	1583
2025 Q2	$850K	Sell	180,000 -10,536	-6%	-$46.1K	﹤0.01%	1542
2025 Q1	$875K	Buy	+190,536	New	+$888K	﹤0.01%	1503

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's VNDA Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft sold out of Vanda Pharmaceuticals (VNDA) in Q2 2026, closing a stake of 30,000 shares — an estimated $207K sold.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in VNDA in Q1 2025 and held it in 5 quarters. The position peaked at $898K in Q3 2025. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft reported no remaining Vanda Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Universal-Beteiligungs- und Servicegesellschaft sold 30,000 Vanda Pharmaceuticals shares in Q2 2026, an estimated $207K.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in Vanda Pharmaceuticals in Q1 2025 and held it in 5 quarters.
Universal-Beteiligungs- und Servicegesellschaft's Vanda Pharmaceuticals position peaked at $898K in Q3 2025.
172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.